JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hitoshi Ogino
Kenji Minatoya
Hitoshi Matsuda
Motomi Ando
Soichiro Kitamura
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Ogino, H.
Right arrow Articles by Kitamura, S.
PubMed
Right arrow Articles by Ogino, H.
Right arrow Articles by Kitamura, S.
Related Collections
Right arrow Cerebral protection
Right arrow Extracorporeal circulation
Right arrow Great vessels

J Thorac Cardiovasc Surg 2008;136:641-649
© 2008 The American Association for Thoracic Surgery


Surgery for Acquired Cardiovascular Disease

Evolving arch surgery using integrated antegrade selective cerebral perfusion: Impact of axillary artery perfusion

Hitoshi Ogino, MDa,*, Hiroaki Sasaki, MDa, Kenji Minatoya, MDa, Hitoshi Matsuda, MDa, Hiroshi Tanaka, MDa, Hirotaka Watanuki, MDa, Motomi Ando, MDb, Soichiro Kitamura, MDa

a Department of Cardiovascular Surgery, National Cardiovascular Center, Aichi, Japan
b Department of Thoracic Surgery, Fujita Health University, Aichi, Japan

Received for publication October 17, 2007; revisions received December 21, 2007; accepted for publication February 19, 2008.

* Address for reprints: Hitoshi Ogino, MD, Department of Cardiovascular Surgery, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, 565-8565, Japan. (Email: hogino{at}hsp.ncvc.go.jp).

Objective: The study objective was to determine the impact of integrated antegrade selective cerebral perfusion with right axillary artery perfusion during arch surgery.

Methods: All surgeries were performed through a median sternotomy. Direct cannulation of the right axillary artery in the axilla was used for cardiopulmonary bypass and antegrade selective cerebral perfusion under hypothermia. In addition, ascending aortic or femoral artery perfusion was used. The clinical records of 531 patients (median age, 72 years) between 1999 and 2006 were reviewed, of whom 137 patients (25.8%) underwent emergency surgery. There were 164 dissecting and 367 nondissecting aortic lesions. The surgeries included total arch replacement in 431 patients, partial arch replacement in 9 patients, and hemiarch replacement in 91 patients.

Results: The early mortality rate was 4.0% (2.3% of 30-day mortality and 1.7% of in-hospital mortality). The incidence of permanent neurologic dysfunction was 2.9% in all (3.3% in total arch replacement and 1.0% in hemiarch or partial arch replacement). The incidence of temporary dysfunction was 9.9% in all (10.6% in total arch replacement and 7.0% in hemiarch or partial arch replacement). Multivariate analysis demonstrated that the risk factors for early mortality were chronic renal failure, ruptured nondissecting aneurysm, and prolonged surgery. The midterm survival was 87.2% ± 1.7% at 3 years and 80.5% ± 2.6% at 5 years.

Conclusion: Right axillary artery perfusion is an advantageous adjunct to cardiopulmonary bypass and antegrade selective cerebral perfusion in arch surgery.



Abbreviations and Acronyms CPB = cardiopulmonary bypass; RAxA = right axillary artery; SCP = selective cerebral perfusion








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.